128 related articles for article (PubMed ID: 32117753)
1. A Cost-Effectiveness and Quality of Life Analysis of Different Approaches to the Management and Treatment of Localized Prostate Cancer.
Harat A; Harat M; Martinson M
Front Oncol; 2020; 10():103. PubMed ID: 32117753
[TBL] [Abstract][Full Text] [Related]
2. Cost-Effectiveness of Active Surveillance, Radical Prostatectomy and External Beam Radiotherapy for Localized Prostate Cancer: An Analysis of the ProtecT Trial.
Sharma V; Wymer KM; Borah BJ; Barocas DA; Thompson RH; Karnes RJ; Boorjian SA
J Urol; 2019 Nov; 202(5):964-972. PubMed ID: 31112105
[TBL] [Abstract][Full Text] [Related]
3. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
4. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
[TBL] [Abstract][Full Text] [Related]
5. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis of single fraction of stereotactic body radiation therapy compared with single fraction of external beam radiation therapy for palliation of vertebral bone metastases.
Kim H; Rajagopalan MS; Beriwal S; Huq MS; Smith KJ
Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):556-63. PubMed ID: 25680599
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of ultra-hypofractionated radiotherapy and conventionally fractionated radiotherapy for intermediate- to high-risk localized prostate cancer.
He J; Wang Q; Hu Q; Li C
Front Oncol; 2022; 12():841356. PubMed ID: 36713549
[TBL] [Abstract][Full Text] [Related]
8. Lifetime Health and Economic Outcomes of Active Surveillance, Radical Prostatectomy, and Radiotherapy for Favorable-Risk Localized Prostate Cancer.
Degeling K; Corcoran NM; Pereira-Salgado A; Hamid AA; Siva S; IJzerman MJ
Value Health; 2021 Dec; 24(12):1737-1745. PubMed ID: 34838271
[TBL] [Abstract][Full Text] [Related]
9. Systematic review of the cost effectiveness of radiation therapy for prostate cancer from 2003 to 2013.
Amin NP; Sher DJ; Konski AA
Appl Health Econ Health Policy; 2014 Aug; 12(4):391-408. PubMed ID: 25022451
[TBL] [Abstract][Full Text] [Related]
10. The impact of life expectancy on cost-effectiveness of treatment options for clinically localized prostate cancer.
Naser-Tavakolian A; Venkataramana A; Spiegel B; Almario C; Kokorowski P; Freedland SJ; Anger JT; Leppert JT; Daskivich TJ
Urol Oncol; 2023 Apr; 41(4):205.e1-205.e10. PubMed ID: 36737259
[TBL] [Abstract][Full Text] [Related]
11. Cost-Effectiveness Analysis of Second-Line Chemotherapy Agents for Advanced Gastric Cancer.
Lam SW; Wai M; Lau JE; McNamara M; Earl M; Udeh B
Pharmacotherapy; 2017 Jan; 37(1):94-103. PubMed ID: 27870079
[TBL] [Abstract][Full Text] [Related]
12. A cost-utility analysis of laparoscopic radical prostatectomy and robotic-assisted laparoscopic radical prostatectomy in men with localized prostate cancer in Thailand.
Ratchanon S; Apiwattanasawee P; Prasopsanti K
J Med Assoc Thai; 2015 Jan; 98 Suppl 1():S14-20. PubMed ID: 25764608
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of stereotactic body radiation therapy versus intensity-modulated radiation therapy: an emerging initial radiation treatment option for organ-confined prostate cancer.
Hodges JC; Lotan Y; Boike TP; Benton R; Barrier A; Timmerman RD
J Oncol Pract; 2012 May; 8(3 Suppl):e31s-7s. PubMed ID: 22942832
[TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness of hypofractionated versus conventional radiotherapy in patients with intermediate-risk prostate cancer: An ancillary study of the PROstate fractionated irradiation trial - PROFIT.
Zhou K; Renouf M; Perrocheau G; Magné N; Latorzeff I; Pommier P; Créhange G; Paumier A; Bera G; Martin J; Catton C; Bellanger M; Supiot S
Radiother Oncol; 2022 Aug; 173():306-312. PubMed ID: 35772576
[TBL] [Abstract][Full Text] [Related]
15. Evaluating the Cost-Effectiveness of Hydrogel Rectal Spacer in Prostate Cancer Radiation Therapy.
Levy JF; Khairnar R; Louie AV; Showalter TN; Mullins CD; Mishra MV
Pract Radiat Oncol; 2019 Mar; 9(2):e172-e179. PubMed ID: 30342180
[TBL] [Abstract][Full Text] [Related]
16. Comparative Cost-effectiveness of the Baerveldt Implant, Trabeculectomy With Mitomycin, and Medical Treatment.
Kaplan RI; De Moraes CG; Cioffi GA; Al-Aswad LA; Blumberg DM
JAMA Ophthalmol; 2015 May; 133(5):560-7. PubMed ID: 25741886
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of degarelix for advanced hormone-dependent prostate cancer.
Lu L; Peters J; Roome C; Stein K
BJU Int; 2012 Apr; 109(8):1183-92. PubMed ID: 21883830
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness Analysis Comparing Conventional, Hypofractionated, and Intraoperative Radiotherapy for Early-Stage Breast Cancer.
Deshmukh AA; Shirvani SM; Lal L; Swint JM; Cantor SB; Smith BD; Likhacheva A
J Natl Cancer Inst; 2017 Nov; 109(11):. PubMed ID: 29059428
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of preoperative motor mapping with navigated transcranial magnetic brain stimulation in patients with high-grade glioma.
Butenschön VM; Ille S; Sollmann N; Meyer B; Krieg SM
Neurosurg Focus; 2018 Jun; 44(6):E18. PubMed ID: 29852777
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness Analysis of Active Surveillance Strategies for Men with Low-risk Prostate Cancer.
Sathianathen NJ; Konety BR; Alarid-Escudero F; Lawrentschuk N; Bolton DM; Kuntz KM
Eur Urol; 2019 Jun; 75(6):910-917. PubMed ID: 30425010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
